Introduction
============

The search for eternal youth has always been a central idea in the history of mankind, as aging and ultimately death represents a startling and inevitable fate for all living organisms. Although the philosophers' stone has not been found yet, it can be considered one of the major achievements of our civilization that human life expectancy has been rising by 2.5 years/decade in a linear manner from the middle of the 19th century ([@B104]). However, the increasing proportion of older individuals in our society raises problems that come from the nature of aging, i.e., the functional decline in the health of the elderly. Strikingly, aging is the main risk factor for the major chronic and killer diseases such as dementia, cardiovascular disease, and cancer ([@B102]), and the prevalence of these diseases increases nearly exponentially with age. As taking care of diseased elderly represents a significant social and economic burden on society, there is increasing pressure on biomedical scientists to come up with ways of extending healthspan along with increased lifespan ([@B44]).

To intervene in the process of aging, the first step would be to elucidate the mechanisms underlying aging, and then to find ways of maintaining health through the manipulation of these mechanisms ([@B107]). We still do not know how cellular function is exactly disrupted during aging, but we can obviously see the complexity of the process as it tends to affect practically all organs and tissues. By looking at it from a bird's eye view, it seems to be an almost impossible quest to pinpoint one single cause underlying the aging process or to ameliorate all aspects of aging simultaneously in various tissues. However, the correlation of age with the increased prevalence of diseases with seemingly different pathological features may suggest the existence of common background mechanisms. Importantly, several features of aging on the level of individual organs and tissues can be deduced from compromised cell functions. As an attempt to give a conceptual framework for the field of aging research, these characteristics have recently been summarized as the nine hallmarks of aging ([@B83]). Acknowledging that these hallmarks are interconnected, the authors grouped them into three hierarchical categories: (1) primary hallmarks (2), antagonistic hallmarks and (3) integrative hallmarks. As the first category, primary hallmarks of aging have unequivocally negative effects on normal cellular function and are considered to be the main causes of cellular damage. These five hallmarks are genomic instability, telomere erosion, epigenetic alterations, mitochondrial dysfunction, and loss of proteostasis. Damage accumulated through these processes triggers compensatory responses representing the second category, the two antagonistic hallmarks of aging: altered nutrient sensing and cellular senescence. These mechanisms initially mitigate the damage, but upon reaching a chronic level they subvert their purpose and become deleterious themselves. For example, cellular senescence at low level can protect the organism from cancer (by blocking the proliferation of damaged and potentially oncogenic cells), but may promote aging after reaching a higher intensity. Ultimately, damage progressively accumulated by the primary and antagonistic hallmarks will overload the compensatory capacity of cellular homeostasis and manifest in the third category, the two integrative hallmarks of aging. These are stem cell exhaustion and altered intercellular communication (most prominently a chronic, systemic inflammation) which are eventually responsible for the functional decline during aging.

Besides the description of the characteristics of the aging process, the most significant finding of aging research is that aging now is considered to be a malleable process ([@B41]). The lifespan of organisms can be extended by both environmental and genetic traits and more importantly, their healthspan can simultaneously be improved during aging, which shows that it is possible to reach the ultimate goal of aging research. Recently, a growing body of evidence shows that alterations of autophagy, the main self-degradative process of eukaryotic cells, likely plays a central role in the aging process. Observations in various organisms indicate that aging and autophagy have a bidirectional connection with each other ([@B122]; [@B47]). On one hand, autophagic degradation shows an age-dependent decline and impairment of autophagy contributes to the development of age-associated diseases ([@B82]; [@B16]; [@B17]). On the other hand, lifespan-extending interventions largely depend on the autophagy machinery for their beneficial effects on longevity ([@B148]; [@B2]; [@B35]). Strikingly, multiple longevity pathways seem to converge on autophagy, and genetic or environmental factors that affect lifespan through these pathways at least partly exert their effects via the modulation of autophagy. These observations point to the key role of autophagy in aging, and suggest that increased autophagy may compensate for at least some of the cellular hallmarks of aging. Thus, the housekeeping functions of autophagy can counteract the accumulation of cellular damage, which is considered to be a primary mechanism driving aging.

The fact that the aging process and its hallmarks are similar in all organisms points to its strong evolutionary conservation, and offers a unique way to understand the aging process by observations made in various model organisms ([@B41]). Amongst experimental animals, research in the fruit fly *Drosophila melanogaster* contributed greatly to our understanding of the underlying mechanisms of both aging and autophagy ([@B95]; [@B47]). In this review, we give a brief historical outline of the milestones reached in these increasingly interweaving research fields and highlight key discoveries made in Drosophila. We also give an overview of how aging and age-related diseases manifest in fly tissues and how these phenomena connect to autophagy. We summarize the cellular signaling networks that regulate aging and autophagy and the established ways of modulating these processes, including pharmacological interventions that may counteract aging at least partly via the modulation of autophagy.

Drosophila as a Model to Study Autophagy and Aging
==================================================

Historical Overview of Aging Research and the Main Mechanisms Involved in the Regulation of Lifespan
----------------------------------------------------------------------------------------------------

Fasting has been practiced for millennia mainly due to religious reasons, and the first scientific report showing that reduced food intake can prolong lifespan was published in 1935 ([@B92]). [@B92] showed that dietary restriction (DR) extends the lifespan of laboratory rats in the first scientifically accurate observation of the effect of an environmental factor on longevity, which represents the beginning of aging research. Although the effect of DR on lifespan was successfully reproduced in various model and non-model organisms, it took another 48 years to find the first evidence that genetic factors are also involved in the regulation of lifespan. The first single-gene mutation leading to extended lifespan was the *daf-2* mutant strain of *C. elegans* ([@B73]), and this discovery represents the first mechanistic connection between nutrient sensing and longevity: the protein encoded by *daf-2* turned out to be the single insulin/insulin-like growth factor receptor of the worm ([@B67]; [@B72]). The central and evolutionarily conserved role of this signaling pathway in longevity was firmly established in the following years, as further members of the pathway were also identified through the isolation of long-lived mutants of *C. elegans* and other laboratory organisms as well. In Drosophila, the first such long-lived mutants were a heteroallelic combination of hypomorphic insulin receptor gene alleles, and null mutants of the *chico* gene encoding the single Drosophila insulin receptor substrate protein ([@B22]; [@B144]). Importantly, mice mutant for members of this pathway were also found to be long-lived ([@B50]; [@B130]), and natural genetic variants of the components of the pathway turned out to be associated with longevity in humans ([@B109]).

Strikingly, these studies also showed that both DR- and mutation-induced lifespan extensions are accompanied by a broad spectrum of health improvements involving tissues that seemingly do not have any connection with each other. This shows the malleability of aging and presumes the existence of mechanisms that mediate these beneficial effects. Decreased activity of TOR kinase is likely crucial for mediating such effects, because mutations in the components of this pathway increase lifespan in various organisms including humans ([@B55]; [@B65]; [@B63]; [@B108]). The TOR complex integrates cellular nutritional and other signals, and acts as the central positive regulator of growth and inhibitor of autophagy. Under nutrient-scarce conditions, reduced TOR activity leads to downregulation of cap-dependent protein synthesis and unleashes autophagy, thus liberating building blocks and energy from autophagic cargo. Strikingly, multiple drugs with lifespan-extending effects modulate the TOR pathway and require autophagy for their beneficial effects. These observations point to a central role of the insulin/TOR signaling network and autophagy in promoting longevity.

Historical Overview of Autophagy Research and the Process of Autophagy
----------------------------------------------------------------------

The history of autophagy research can be divided into two major chronological periods ([@B95]). Studies of the early era that were primarily based on ultrastructural analyses mainly provided descriptive data. This approach was somewhat superseded by the tools of the genomic era allowing mechanistic analysis and the use of specific marker proteins. The first properly interpreted electron microscopic images of mitochondria-containing lysosomes were taken in the proximal tubule cells of rat kidney by [@B103], and during the next decades, ultrastructural analyses in various tissues revealed the morphological stages of the autophagic process. The first observations that pointed to a connection between the insulin pathway and autophagy showed that the process can be induced by glucagon and inhibited by insulin ([@B32]; [@B111]). Drosophila was an important experimental organism even in the early era, and the first report of autophagic structures in larval fat body cells dates back to 1963 ([@B155]). During the 1970s and 1980s, ultrastructural analyses showed that fat body cells accumulate large amounts of stored nutrients that can be mobilized through developmentally programmed autophagy controlled by the molting hormone ecdysone ([@B12]). This intensive catabolic process ultimately leads to the decomposition of this tissue, thus providing building blocks and energy for the metamorphosis of the fly larvae. The first genes involved in the molecular mechanism of autophagy were identified in yeast at the beginning of the 1990s ([@B149]). This milestone revolutionized autophagy research and gave new momentum to the field. The fundamental importance of autophagy and the discovery of Atg (autophagy-related) genes were acknowledged with a Nobel-prize awarded to Yoshinori Ohsumi in 2016. Notably, Drosophila was the first animal in which an Atg gene was characterized. It was shown that the product of *draut1/Atg3* is essential for autophagy and proper development ([@B57]). Since then, a still expanding genetic toolkit and sophisticated experimental approaches have been developed to study autophagy in Drosophila ([@B91]; [@B101]; [@B85]; [@B140]). Interestingly, both starvation-induced and ecdysone-mediated developmental autophagy turned out to be initiated by the downregulation of the insulin signaling pathway ([@B123]; [@B129]). Importantly, an early study showed that loss of Atg7 decreases lifespan in Drosophila ([@B59]).

These results suggested a connection between insulin signaling, autophagy and longevity and in the last decade, several key discoveries of this field were achieved by using the Drosophila model. Systemic effects of tissue-specific modulation of autophagy on organismal aging were first observed in the fruit fly: neuronal overexpression of *Atg8a* or *Atg1* were shown to be sufficient to extend lifespan ([@B133]; [@B151]), and the overexpression of *Atg1* also improved intestinal barrier function. The loss of proteostasis during muscle aging was linked to decreased autophagy and organismal aging ([@B29]), and the requirement for autophagy was shown in a conserved longevity paradigm involving mTOR inhibition in the fly model ([@B9]). Importantly, a direct connection between Parkin, a key regulator of mitophagy and longevity was established by the discovery that *parkin* overexpression is sufficient to extend Drosophila lifespan ([@B114]).

Three main mechanisms of autophagy have been described through which cytoplasmic components can reach lysosomes. During chaperone-mediated autophagy, proteins with an exposed KFERQ-like motif are recognized by the Hsc70 chaperone and then targeted to the transmembrane LAMP2a protein located in the lysosomal membrane ([@B26]). With the possible contribution of other chaperones, proteins are translocated into the lysosomal lumen through the channel formed by a LAMP2a oligomer. The second type of autophagy that is also linked directly to the lysosomal membrane is microautophagy, during which cytoplasmic components are directly taken up by lysosomes. This way, portions of the cytoplasm and even whole organelles are surrounded by invaginations of the lysosomal membrane, which will eventually pinch off into the lumen of the lysosome ([@B80]; [@B146]). Bulk and selective types are known in the case of both micro- and macroautophagy. Macroautophagy is the best known autophagy pathway and it significantly differs from chaperone-mediated and microautophagy in terms of its mechanisms ([@B37]). Macroautophagy requires the formation of a new organelle: the autophagosome, in which cytoplasmic components are sequestered prior to their degradation by the lysosome. As the first step of this process, a membrane cistern called the phagophore (or isolation membrane) forms in the cytoplasm. The growing phagophore surrounds a portion of the cytosol, and the sealing of its edges leads to the formation of the double-membrane autophagosome. This process depends on the evolutionarily conserved set of Atg genes ([Table 1](#T1){ref-type="table"}). The outer membrane of this transient vesicular organelle then fuses with lysosomes (or first with late endosomes) to give rise to autolysosomes (or amphisomes), in which lysosomal degradation of the inner autophagosomal membrane as well as the cargo takes place. While macroautophagy has originally been considered to be a bulk, non-selective process, several subtypes of selective autophagy have been described by now that transport particular structures for lysosomal degradation including pexo-, mito-, aggre-, reticulo-, lipo-, and ribophagy ([@B120]). Amongst the three types, macroautophagy (hereafter referred to as autophagy) has the largest capacity and is considered to be the main clean-up process of eukaryotic cells. Importantly, a basal level of autophagy proved to be essential in maintaining normal cell function through the removal of damaged and obsolete cellular components ([@B74]). In addition, autophagy is known to be induced by starvation or other stresses that cells encounter, which often signals through the downregulation of TOR kinase.

###### 

Drosophila autophagy-related genes and their functional analyses.

  Atg proteins in *Drosophila*   Function                                                            Loss of function phenotype                                                                            Gain of function phenotype                                                                                                                                      References
  ------------------------------ ------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------
  Atg1                           Serine/threonine kinase                                             Short lived, oxidative stress response defects, reduced dendritic growth, autophagy defect            Extended lifespan, improved intestinal barrier, reduced cell size, induced autophagy, induction of apoptosis, and organismal death upon strong overexpression   [@B129], [@B128]; [@B160]; [@B113]; [@B18]; [@B97]; [@B151]; [@B110]; [@B24]
  Atg2                           Lipid transporter for autophagosome biogenesis                      Short lived, decreased cell death, reduced dendritic growth, autophagy defect                         --                                                                                                                                                              [@B129]; [@B113]; [@B18]; [@B96]; [@B162]; [@B24]; [@B152]
  Atg3 (aka. Aut1)               E2-like enzyme, Atg8 ligase activity                                Short lived, autophagy defect                                                                         --                                                                                                                                                              [@B57]; [@B128]; [@B18]; [@B110]; [@B153]
  Atg4a                          Cysteine-type endopeptidase                                         Accumulation of p62 positive aggregates, autophagy defect                                             --                                                                                                                                                              [@B113]; [@B110]
  Atg4b                          Cysteine-type endopeptidase                                         --                                                                                                    --                                                                                                                                                              --
  Atg5                           Atg8 ligase activity                                                Memory defect, autophagy defect, ataxia, reduced dendritic growth, impaired immune function           --                                                                                                                                                              [@B129]; [@B116]; [@B18]; [@B110]; [@B71]; [@B24]; [@B8]
  Atg6                           Autophagosome assembly, late endosome-lysosome maturation           Autophagy defect, melanotic mass formation                                                            --                                                                                                                                                              [@B18]; [@B132]; [@B84]; [@B110]
  Atg7                           E1-type ligase, Atg8 and Atg12 activator enzyme                     Short lived, memory defect, impaired immune function, autophagy defect                                Extended lifespan                                                                                                                                               [@B129]; [@B59]; [@B116]; [@B20]; [@B36]; [@B113]; [@B18]; [@B96]; [@B110]; [@B153]
  Atg8a                          Ubiquitin like protein, autophagosome assembly                      Reduced dendritic growth, autophagy defect                                                            Extended lifespan                                                                                                                                               [@B128]; [@B133]; [@B113]; [@B18]; [@B96]; [@B151]; [@B110]; [@B24]
  Atg8b                          Ubiquitin like protein                                              --                                                                                                    --                                                                                                                                                              [@B133]; [@B110]
  Atg9                           Organization of PAS, response to oxidative stress, JNK activation   Thicker and shorter midgut, memory defect, autophagy defect, short lived                              Induced JNK activation                                                                                                                                          [@B113]; [@B141]; [@B96]; [@B110]; [@B158]; [@B8]
  Atg10                          E2-like enzyme, Atg12 transferase activity                          --                                                                                                    --                                                                                                                                                              --
  Atg12                          Ubiquitin like protein, Atg8 ligase activity                        Reduced immune function, autophagy defect                                                             --                                                                                                                                                              [@B129]; [@B116]; [@B18]; [@B110]
  Atg13                          Atg1 regulator activity                                             Short lived, autophagy defect                                                                         --                                                                                                                                                              [@B19]; [@B113]; [@B18]; [@B97]; [@B66]; [@B93]
  Atg14                          Autophagosome assembly                                              Autophagy defect, decreased stem cell number in the gut                                               --                                                                                                                                                              [@B113]; [@B84]; [@B98]; [@B66]
  Atg16                          Atg8 ligase activity                                                Defective immune responses, inflammation, thicker and shorter midgut, short lived, autophagy defect   --                                                                                                                                                              [@B113]; [@B18]; [@B153]; [@B100]
  Atg17 (aka. FIP200)            Atg1 regulator activity                                             Short lived, autophagy defect                                                                         Enhanced autophagy                                                                                                                                              [@B70]; [@B97]

Characteristics of Aging Drosophila Tissues and Their Contribution to Organismal Aging
======================================================================================

Aging manifests in several ways on the cellular and organismal level and age-associated phenotypes are seen in various tissues, which ultimately lead to the development of diseases linked to aging. There is a growing body of evidence (see below) supporting correlations between the aging rate of a given tissue and that of the whole organism. However, we still do not know whether it is the aging of a single, critical tissue (e.g., the brain or the gut) that determines aging rate on the organismal level or if it arises from the combination of defects affecting multiple tissues. In this chapter we highlight some tissues that may have such rate-limiting properties during aging.

Fat Tissue
----------

As the equivalent of mammalian hepatocytes and white adipocytes, the main function of the Drosophila fat tissue is the uptake, metabolism and storage of nutrients that enter the hemolymph after initial processing in the gut. During the development of the almost continuously feeding fly larva, fat body cells undergo an enormous, more than 200-fold increase in size (accompanied by a 256--512 fold polyploidization) thanks to intensive nutrient storage in the cytoplasm. Importantly, this anabolic process can be transiently reversed by starvation, during which the induction of autophagy liberates nutrients from fat cells to the hemolymph to ensure the survival of the diploid larval tissues ([@B95]). These tissues will give rise to the organs of adult flies in parallel with the breakdown of polyploid larval organs during metamorphosis. The disintegration of these polyploid tissues (including the fat body, gut and salivary glands) is initiated by a peak of the molting hormone ecdysone, and the process is executed by a massive, irreversible autophagy induction in fat and gut cells. The fat tissue initially decomposes to individual cells, half of which die during metamorphosis and their liberated components are used as building blocks and to provide energy for the development of adult tissues. Notably, as dying fat cells are full of autophagic structures, this process was often referred to as programmed cell death type II or autophagic cell death ([@B13]). Interestingly, the other half of the larval fat cells survive to the first days of adulthood and die through caspase-dependent cell death ([@B1]). This self-sacrifice nicely demonstrates the central role of fat cell autophagy in the nutrient handling and allocation during the postembryonic development of Drosophila.

Importantly, a picture is emerging about a more complex role of fat tissue beyond providing nutrients for other tissues through self-cannibalism. Besides being an important storage organelle, the fat tissue also acts as a main sensor of nutrients and a central regulator of systemic insulin signaling and longevity ([@B145]). It has been shown previously that inhibition of amino acid transport specifically in the fat tissue leads to reduced organismal growth ([@B25]), and the molecular components and main mechanisms of this effect were identified in the past decade. The mediators of this regulatory network are humoral factors: the Drosophila insulin-like peptides (DILPs). These proteins are secreted by fat cells and 14 neurosecretory insulin-producing cells (IPCs) located in the larval and adult brain. Based on sequence similarity, seven Drosophila *dilp* loci have been identified ([@B11]; [@B15]). Expression of *dilp1, dilp2, dilp3*, and *dilp5* is high in IPCs whereas *dilp6* is highly expressed in the fat tissue. During starvation, reduced TOR signaling leads to FOXO activation and in turn to the increased expression and secretion of DILP6 in fat cells. Circulating DILP6 then causes the retention of DILP2 and DILP5 proteins in IPCs (that may not be capable of nutrient sensing on their own), and reduced DILP secretion leads to organism-wide reduction of insulin-signaling and extended lifespan ([@B40]; [@B7]). Thus, the reduced level of nutrients in the hemolymph induces autophagy in fat cells in a cell-autonomous manner, and fat cells downregulate systemic insulin signaling cell-non-autonomously that results in restricted growth and extended lifespan.

Recently, another non-cell-autonomous function of fat tissue was shown to have an effect on aging. [@B5] showed that in the fat body cells of the adult flies, there is a strong correlation between the aging process and the activation of immune-related genes. The expression levels of the NF-κB like transcription factor *Relish* and its target genes encoding antimicrobial peptides (AMPs) such as *attacins (A, C, D), cecropinA1, defensin, diptericin, drosocin, drosomycin*, and *metchnikowin* are increased during the aging process in the adult fat body. The fat body specific overexpression of *Relish* led to increased levels of AMPs, which strongly correlated with shortened Drosophila adult lifespan. Furthermore, the reduced expression of *Relish* decreased the levels of AMPs and these genetically manipulated animals showed an extended lifespan. These findings show that the activation of immune related genes positively correlates with aging phenotypes in fat cells of adult flies, which is the hallmark of the age-associated immune response. The authors also showed that overexpression of individual AMPs such as *attacinA, cecropinA1, defensin* and *metchnikowin*, but not *drosocin* and *drosomycin*, may contribute to shorter lifespan, possibly via cytotoxicity and higher apoptotic levels. But how can these factors promote aging and apoptosis, and why is autophagy important in the prevention of this process? One could speculate that AMPs cause mitochondrial depolarization and lead to apoptosis in fat cells, contributing to the aging phenotype this way. Autophagy is important in the recognition, sequestration and elimination of damaged mitochondria ([@B106]; [@B121]; [@B112]), and high levels of mitophagy may protect the adult fat cells from early aging and apoptosis.

Oenocytes also fulfill liver-like functions in Drosophila and show interesting biochemical and molecular changes during aging ([@B51]). In this article, the authors identified the main molecular alterations of aging oenocytes using cell type-specific ribosome profiling (RiboTag). They find that some of the age-regulated genes that are involved in oxidative phosphorylation, fatty acid metabolism, proteasome function and cytochrome P450 pathways are downregulated in aged oenocytes. Interestingly, the levels of most peroxisomal genes such as components of fatty acid β-oxidation and peroxisome biogenesis also decreased. In contrast, the immune-response pathways, Ras/MAPK signaling and DNA replication are upregulated in this condition. These findings suggest that certain molecular alterations greatly contribute to the aged cell phenotype.

Intestine
---------

The gastrointestinal tract is a very important and specialized microenvironment in the animal body. In the fly gut, nutrients from the digested food are absorbed via the intestinal epithelial cells (enterocytes), which utilize septate junctions to form an effective barrier against pathogens ([@B126]; [@B4]; [@B78]). The intestine has diverse regions, which contain morphologically and histologically different epithelial cells in Drosophila. The main regions of the midgut (anterior, middle, and posterior) and further sub-regions can be distinguished from each other based on their different expression profiles ([@B4]; [@B94]). The intestine also has other important functions such as metabolism and immune homeostasis ([@B54]).

The turnover and quick regeneration of the intestinal epithelium is ensured by intestinal stem cells. Maintenance of epithelial integrity and barrier function in the gut via the activity of intestinal stem cells is absolutely critical for longevity. During aging, the barrier function of intestinal epithelia deteriorates, which is detrimental for Drosophila lifespan ([@B117]; [@B23]). The composition of the intestinal microbiota also dramatically changes during aging. Expansion of several bacteria such as Gamma-proteobacteria is associated with the breakdown of the epithelial barrier via the activation of an intestinal immune response ([@B23]).

One of the main mechanisms that maintains intestinal stem cell functions and homeostasis is autophagy. Autophagy dysfunction during aging can lead to increased DNA damage, cell cycle arrest and apoptosis ([@B99]). After an initial hyperplasia phenotype ([@B150]), the thinning of the intestinal wall is seen over time in most Atg gene mutants and RNAi animals. However, the midguts of *Atg9, Atg16*, and *Atg101* mutant flies are much thicker and shorter compared to controls, which is likely at least in part due to altered TOR kinase signaling and differentiation defects of intestinal stem cells, respectively ([@B100]; [@B158]; [@B45]).

Immune Responses
----------------

Although the number of infection-related deaths are decreasing among the elderly in well-developed Western societies, these still remain a major factor in determining longevity. An elegant study recently showed that stochastic variation in immune responses determines the survival of isogenic, co-housed Drosophila adults upon infection ([@B33]). The central importance of stochastic variation in life or death decisions is rather unappreciated, but it is likely of general importance in aging-related mortality as well.

Muscle
------

In Drosophila, the structure and function of skeletal muscle fibers is similar to that of mammals. During aging, the decay of muscle function presents as decreased muscle strength (muscle quality) and reduction in total muscle mass (muscle quantity) known as sarcopenia ([@B30]). Unlike in mammals, muscle stem cells called satellite cells have not been identified in adult insects, so fly skeletal muscle cells are not replenished during aging and thus undergo a more dramatic age-related decline. This fundamental difference explains the more apparent morphological and functional alterations in aging Drosophila skeletal muscle compared with mammals, and it is supposedly related to the relatively short lifespan of flies ([@B30]). During aging, muscle cells accumulate malfunctioning mitochondria and protein aggregates as a consequence of imbalanced proteostasis, which both contribute to muscle dysfunction. Importantly, autophagy selectively removes both protein aggregates and dysfunctional mitochondria, so its decline is likely a major reason for aging-related changes.

In line with this, loss of the transmembrane protein Atg9 or its partners Atg2 or Atg18 in heart and flight muscles caused shortened lifespan in Drosophila. The knockdown flies showed cardiac hypertrophy and structural abnormalities in the heart, resembling the age-dependent decline of cardiac functions ([@B161]). In these autophagy defective heart cells, abnormal elongated mitochondria were observed and the number of mitochondria captured in autophagosomes was reduced. Interestingly, the flight muscle cells contained fewer mitochondria that were often fragmented.

Aging of the skeletal muscle has a strong impact on nutrient sensing and global aging in part because myokines, muscle-derived cytokines and growth factors, modulate systemic physiology and aging, so proper muscle function is critical for longevity ([@B30]). In Drosophila, the skeletal muscle transcription factor Mnt induces myoglianin (Myo) production, which is a transforming growth factor-β (TGF-β) ligand, and it decreases nucleolar size and ribosomal RNA level in the fat body. Overexpression of both Mnt and Myo increase longevity of flies ([@B28]) Besides this, muscle produces ImpL2 as well (the ortholog of human insulin-like growth factor-binding protein 7), which elevates the number of lysosomes and may promote increased autophagic flux in skeletal muscle. ImpL2 inhibits overall insulin signaling, thus it can contribute to the lifespan extension of flies through the above mentioned mechanisms ([@B105]).

Nervous System
--------------

Neurons are specialized cells for integrating, processing and transmitting information. Our brain consumes 20% of total blood glucose even though its weight is only about 2.5% of that of our body, demonstrating how high the neuronal metabolic activity is. Besides these, neurons have specialized structures for information delivery: axons, dendrites, and synapses. Quality control of mitochondria and proteins in the axon and synapse is crucial for maintaining the proper functioning of neurons, and since these cells are post-mitotic, it predisposes them for the accumulation of defective organelles and toxic proteins. That is why autophagy plays a critical role in normal neural functions, and its failure leads to the accumulation of obsolete cellular components, which may result in the development of neurodegenerative diseases. The first report of an autophagy gene null mutant in Drosophila showed that loss of Atg7 leads to the accumulation and aggregation of undegraded proteins in the cytoplasm, premature neuronal aging and apoptosis, ataxia and short lifespan ([@B59]). Several other components of the autophagic machinery including Atg17/FIP200 ([@B70]), Atg8a ([@B133]), Atg9 ([@B158]), and Atg16 ([@B153]) were also found to be essential for the maintenance of proper neural functions and normal lifespan. Importantly, the neuron-specific overexpression of *Atg8a* was found to induce longevity, presumably through enhanced autophagy ([@B133]). SNARE proteins promote vesicle fusions, and by now the SNAREs necessary for autophagosome clearance are also known: SNAP-29, Vamp7 and the autophagosomal Syntaxin 17 (Syx17). In *Syx17* mutant flies, autophagosomes accumulate in all cells including neurons ([@B139]), which also leads to neuromuscular dysfunction as indicated by their poor performance in climbing tests, and to early death of the animals.

A typical symptom of aging is memory loss, and a recent study reported that autophagy affects memory function in flies ([@B8]). Impaired autophagy due to silencing of *Atg5* or *Atg9* in the learning center (mushroom body) of the Drosophila brain attenuates associative olfactory memory and decreases the level of neuropeptide Y, which normally acts non-cell-autonomously to promote memory function. Thus, an autophagy-regulated signaling pathway promotes memory formation in flies.

Both normal and pathological, early aging of the nervous system are characterized by impaired energy metabolism, increased oxidative stress and accumulation of protein aggregates. This latter phenomenon is often investigated in Drosophila, which is a popular model for neurodegeneration. Autophagy plays a pivotal role in maintaining the integrity of postmitotic neurons, since in the absence of cell division, the damaged organelles and misfolded proteins cannot be "diluted." Perturbed autophagy interferes with intracellular communication in neurons, during which organelles and proteins should be transported to relatively high distances from the perikaryon. In particular cases including Alzheimer's and Parkinson's disease, accumulation of disease-specific proteins (see below) can perturb autophagy, which leads to the accumulation of autophagosomes, and contributes to neurodegeneration ([@B135]).

Importantly, age-related dementias (diseases with deterioration of mental abilities during aging) strongly affect life quality. Seventy-five percent of dementias are caused by Alzheimer's disease, and other common types include vascular dementia and dementia with Lewy bodies ([@B31]). Lewy bodies - composed of α-synuclein -- can also be found in Parkinson's disease, which eventually causes dementia, too. Mutations in the huntingtin gene (*HTT*) are responsible for the onset of Huntington's disease (HD), and 50% of people with advanced HD develop dementia as well. Mixed typed dementias occur when the patient suffers from multiple different dementias; the most frequent is when Alzheimer's disease and vascular dementia occur at the same time ([@B31]).

Based on the estimation by the Alzheimer's Society, 44 million people may be suffering from this disease worldwide (5--7% of all people above 60 years), and this number will double in every 20 years ([@B31]). Approximately one third of the people with dementia live in care homes, the remainders often need a primary caregiver (mainly a family member), which means extra expenses for the individuals and for the society as well. Thus, developing new therapies, which target the causes of the diseases or slow their progression, is a pressing need.

The most challenging part of neurodegenerative disease research is the identification of the triggering causes, because approximately 90% of the Parkinson's ([@B142]) and Alzheimer's disease ([@B39]) cases are sporadic without a clear genetic link. Although we are still far from understanding the molecular mechanisms of disease onset and progression, boosting the autophagic turnover of proteins and organelles will likely be beneficial for the treatment of dementia (please see the recent reviews: [@B10]; [@B47]).

Signaling Pathways Involved in the Regulation of Autophagy and Aging
====================================================================

TOR Ser/Thr Kinase
------------------

Target of rapamycin (TOR) is a member of the phosphatidylinositol kinase-related kinase (PIKK) family. Based on the analysis of the interaction proteome of Drosophila TOR, two main complexes were identified: TORC1 and TORC2. TORC1 contains the fly orthologs of the mammalian TORC1 complex: TOR, Raptor, Lobe, Lst8 (dGbL) ([@B43]). TORC1 as a signaling hub has a central role in nutrient-sensing, and hence in the positive regulation of cell growth and anabolic metabolism in eukaryotes. TORC2 is composed of TOR, SIN1, Lst8 and Rictor; it regulates actin polymerization and plays a role in age-associated memory loss of flies ([@B56]). Hereafter we will focus on those functions of TOR that are mediated by the TORC1 complex. TOR kinase activity inhibits autophagy via direct phosphorylation of Atg1, the kinase involved in the initiation of autophagosome formation. TOR deficiency more than doubles the lifespan of *C. elegans* ([@B154]), and TOR kinase inhibitors such as rapamycin enhance autophagy and promote longevity in flies, too ([@B9]). Along these lines, overexpression of the TOR kinase inhibitor TSC1 and TSC2 (tuberous sclerosis complex 1 and 2) proteins were found to increase the lifespan of flies ([@B65]).

FOXO (Forkhead Box O) Transcription Factor
------------------------------------------

FOXO is activated by decreased growth/class I PI3K or increased stress (JNK) signaling through inhibitory and stimulatory phosphorylation events, respectively ([@B138]). FOXO has been shown to be required for growth inhibition, increased stress resistance, and lifespan extension triggered by modulation of these signaling pathways, respectively ([@B61]; [@B157]). The first report of FOXO regulating autophagy came from a Drosophila study, which showed diminished starvation response in *foxo* mutant larvae and that overexpression of activated FOXO is sufficient to induce autophagy in fat cells of feeding larvae ([@B60]). This regulation turned out to be conserved in mammals, too ([@B89]).

The importance of FOXO for longevity was shown in 1983, as its worm homolog *daf-16* was necessary for *daf-2* mutation-induced longevity ([@B73]). However, this study left the question open whether FOXO acts strictly in a cell-autonomous manner during aging. Subsequent studies of Drosophila FOXO showed that activation of FOXO in the adult adipose tissue is sufficient to extend lifespan, via reducing brain-derived DILP2 (Drosophila Insulin-Like Peptide 2) levels and insulin signaling in peripheral tissues ([@B42]; [@B53]). This effect is mediated by FOXO-dependent transcription of *dilp6* in fat cells, which represses DILP2 secretion by neurosecretory cells ([@B7]).

Reduced protein homeostasis, a characteristic feature of aging, is associated with cellular decay over time due to insufficient protein quality control by the ubiquitin-proteasome system (UPS), by the autophagy/lysosome pathway, and by chaperone-mediated protein refolding ([@B77]; [@B83]). Protein quality control defects contribute to age-related muscle weakness, and FOXO and its transcriptional target Thor/4E-BP were found to enhance autophagy to remove damaged proteins. Moreover, *foxo* mutants exhibited proteostasis defects in their muscles. As muscle-specific overexpression of FOXO or 4E-BP promotes longevity and delays the functional decline of muscles with age, as well as modulates organism-wide proteostasis by affecting feeding behavior, this signaling route plays a critical role in the determination of lifespan ([@B29]).

The Insulin-PI3K-Akt Pathway
----------------------------

Similar to the previously mentioned *daf-2/insulin receptor* mutant in worms, reduced activity of this pathway led to longevity in Drosophila. One particular heteroallelic combination of hypomorphic insulin receptor gene alleles resulted in a 85% extension of maximal lifespan ([@B144]). Mutation of *chico*, the single fly homolog of insulin receptor substrate proteins, caused a 48% extension of median lifespan in homozygous and 36% extension in heterozygous form ([@B22]). Importantly, only homozygous mutants had a small body size, indicating that the effect of this pathway on cell/organismal growth is separate from its role in mediating longevity.

Interestingly, PI3K/Akt signaling is not only modulated by insulin and insulin-like growth factors. A recent study showed that mechanical stress is also necessary for the response of fat cells to insulin, both *in vivo* and *ex vivo* ([@B69]). This finding may explain how sedentary lifestyle (that is, reduced mechanical stress to tissues) contributes to insulin insensitivity.

The Activin-like TGF-β superfamily ligand dawdle (*daw*) was found to be repressed by FOXO during reduced insulin/insulin-like growth factor-1 signaling ([@B6]). Loss of *daw* or its downstream transcription factor *Smox* extended lifespan by preserving muscle function and reducing poly-ubiqutinated protein accumulation. It may not be FOXO that directly regulates the transcription of Atg genes because Smox was capable of binding and transcriptionally repressing *Atg8a* in *chico* mutants, and overexpression of *Atg8a* in muscles promoted longevity ([@B6]), similar to its neuronal overexpression ([@B133]).

AMP-Activated Kinase
--------------------

AMP-activated kinase (AMPK) is activated by low energy status manifesting in low ATP and high AMP levels or by its upstream kinase LKB1, which is activated by genotoxic stress and reactive oxygen species. AMPK not only controls glucose and lipid metabolism but also autophagy through direct phosphorylation of ULK1 (one of the mammalian homologs of Atg1 kinase) ([@B34]). Importantly, upregulation of AMPK activity in the adult Drosophila brain increased autophagy both in the brain and intestinal epithelium, and slowed systemic aging ([@B151]). The upregulation of Atg1 in the brain was necessary and also sufficient for these effects. Similarly, upregulation of AMPK in the adult intestine induced autophagy both in cell autonomous and non-cell-autonomous manners and increased longevity. The tissue-specific AMPK/Atg1 activation was again found to reduce brain-derived DILP2 levels and organism-wide elevation of 4E-BP expression, this way slowing aging non-cell-autonomously ([@B151]).

Multiple Longevity-Inducing Paradigms Act Through Autophagy
===========================================================

Modulation of the previously discussed signaling pathways may help living a longer and healthier life. In this chapter we will discuss well-established options to potentially achieve this.

Dietary Restriction
-------------------

Dietary restriction (DR) extends the lifespan of multiple organisms including yeast, worms and flies, and it can slow down the development of many age-related diseases as well. DR is thought to induce a shift from growth and reproduction to somatic maintenance ([@B88]). Importantly, food/calory intake must be reduced without causing malnutrition, which is often achieved by supplementation of the diet with essential nutrients. The main pathways that contribute to nutrient sensing and mediating longevity are TOR kinase and insulin/PI3K/Akt signaling, as mentioned before. The effect of DR on *chico* null mutant versus control flies was assessed under different food concentrations. Both genotypes showed peak lifespan with similar maximum values (55 days), however, *chico* nulls reach this at 0.8x diluted food concentration, while control lifespan was maximal at 0.65x dilution. The authors concluded that *chico* mutation did not further increase the longevity achieved by DR so these manipulations work through overlapping mechanisms ([@B21]), but others recommended further analyses ([@B143]).

Tor signaling is activated by nutrients and growth factors, so DR lowers TOR kinase activity and thus enhances autophagy. TOR also controls ribosomal biogenesis, mitochondrial function, and metabolism and thus its inhibition prefers a basal, "maintenance state" instead of growth, as reviewed in detail elsewhere ([@B64]). Apart from DR, TOR kinase activity can also be modulated pharmacologically as discussed below.

It is important to emphasize that DR can also be mimicked by mutations affecting nutrient transporters on the surface of cells. A well-known example for that is Indy (I'm Not Dead Yet), the fly ortholog of the plasma membrane transporter SLC13A5 ([@B119]). Indy is expressed in tissues with high metabolic activity, and imports citrate and other TCA cycle intermediates. Mutations affecting *Indy* or its worm or mouse homologs extend lifespan and bring about metabolic and physiological changes that are also seen during DR ([@B118]). Promising small molecule inhibitors of Indy that are being developed may turn out to be effective in the treatment of age-related diseases ([@B159]).

Rapamycin
---------

Rapamycin is an antifungal macrolide metabolite, which was discovered in a soil sample collected from Rapa Nui (Easter Island). It is produced by *Streptomyces hygroscopicus* and it has an immunosuppressive and anti-proliferative effect on mammalian cells ([@B79]). Rapamycin and its analogs (rapalogs) are specific TOR inhibitors by engaging FKBP12 to bind to the FKBP12-rapamycin-binding (FRB) domain of TOR. This reduces the phosphorylation of two TORC1 effectors, S6K and 4E-BP. Dephosphorylated 4E-BP then shuts down eIF-4E mediated cap-dependent translation, while Atg1-dependent autophagy and cap-independent translation are upregulated ([@B115]). Genetic inhibition of the Tor pathway promotes longevity in yeast ([@B62]), worms ([@B154]), flies ([@B65]) and mice ([@B131]). [@B9] investigated the effect of rapamycin on lifespan, stress resistance, fecundity and autophagy induction in Drosophila. Different concentrations of rapamycin were administered to the flies to find the effective concentration (50 μM) that gives maximal lifespan extension, which was independent of the TORC2-specific phosphorylation of Akt kinase and AMP-activated protein kinase (AMPK). TORC1 effector pathways were altered upon rapamycin feeding as expected: global translation was inhibited, and the number of LysoTracker-positive (acidic) lysosomes/autolysosomes increased suggesting autophagy induction. Rapamycin acted through autophagy based on experiments with *Atg5* RNAi flies, since its lifespan-elongating effect was abolished in knockdown animals. Moreover, rapamycin treatment increased stress resistance as it also prolonged the survival of flies that were either starved or treated with paraquat (a commonly used oxidative stress inducer). Unfortunately, pharmacological inhibition of human TOR kinase leads to immunosuppression so it is mainly used in organ transplant patients ([@B76]), and as a result the potential use of rapamycin and newer generation TOR kinase inhibitors for lifespan extension therapy is limited.

Exercise
--------

Physical exercise has been implicated in healthy aging, which is especially critical considering the mostly sedentary life and high-calorie diet of modern men ([@B38]). Exercise induces autophagy in skeletal and heart muscle, which is required for the systemic beneficial effects of training in mice ([@B48]). In line with this, combined strength and endurance training of senior people improves both neuromuscular and cardiorespiratory functions ([@B14]). The effect of endurance exercise was also investigated in flies, and it promoted central and peripheral adaptations: improved cardiovascular function and capacity of skeletal muscles to generate energy via oxidative metabolism ([@B137]). Genes that are upregulated after training in a machine called Power Tower ([@B147]) (developed for daily exercise of flies utilizing their negative geotaxis reflex) were identified and compared against genes that are associated with increased lifespan in a fly line generated through selective breeding. Genes coding odorant or gustatory receptors, members of the G-protein coupled receptor encoding methuselah-like family genes, lipases, enzymes in the folate metabolism and stress resistance were found to overlap between trained and long-lived flies. While no autophagy genes were identified in this study, enhanced lysosomal activity was seen in the adipose tissue of both long-lived flies and exercised control flies. These data suggest that autophagy is transiently upregulated in the muscle after exercise in flies as well (similar to mice), leading to stable upregulation of this process in adipose tissue.

Resveratrol
-----------

Resveratrol is one of several polyphenols found in different plants such as grape berry skins, peanuts, blueberries and cranberries. Resveratrol and related agents were suggested to act as a Sirtuin activating compound (STAC), which promotes the deacetylation of proteins by members of the Sir2-like protein family. As the role of sirtuins in lifespan modulation is controversial ([@B87]), the effect of resveratrol is not clear either. A systematic study tested the effect of different concentrations of resveratrol on the lifespan of male and female flies raised on diets with variable amounts of fat, protein and carbohydrate, and only detected longevity in a small subset of conditions, and only in female flies ([@B156]).

Antioxidants
------------

Oxidative stress is thought to be one of the major drivers of the aging process. Both exogenous sources and mitochondria can produce reactive oxygen species (ROS) that then damage organelle membranes, proteins and other molecules inside cells, this way leading to a general malfunctioning over time. Autophagy may potentially circumvent the detrimental effects of oxidative stress via the enhanced turnover of damaged structures ([@B75]). In line with this model, expression of Ndi1 (a mitochondrial yeast NADH dehydrogenase) in Drosophila, which can act in parallel to mitochondrial complex I to reduce mitochondrial ROS production, promotes longevity ([@B125]). However, the direct causal relationship between oxidative stress and lifespan is not clear, because overexpression of the gene encoding alternative oxidase (AOX) decreases mitochondrial ROS production but does not increase lifespan, and *dj1-beta* mutant flies generate more ROS without detrimental effects on longevity ([@B124]).

Spermidine
----------

The polyamine spermidine affects the epigenetic deacetylation of histone H3 through inhibition of histone acetyltransferases (HAT). The intracellular concentration of spermidine decreases during aging, and the lifespan of yeast, worms, flies and in human immune cells can all be extended with the administration of spermidine ([@B35]). Spermidine was taken up and metabolized by flies when their food was supplemented with this polyamine, and it increased their mean lifespan by 30%. Spermidine upregulated the transcription of autophagic genes, and increased the level of lipidated, autophagosome-associated Atg8a in flies and its homolog LC3 in human cells as well as the number of LysoTracker Red-positive (auto)lysosomes ([@B35]).

The age-dependent decline of olfactory memory of Drosophila serves as a model for age-induced memory impairment (AMI). Decreased polyamine level in the heads of aging Drosophila was found to impair the olfactory memory of flies, because normal AMI could be restored with the administration of spermidine ([@B46]). Spermidine enhances autophagy based on elevated Atg8a and decreased p62 levels observed in the brains of old flies on spermidine treatment. Autophagy is essential for mediating the effect of spermidine, since polyamine administration could not restore AMI in *Atg7* or *Atg8a* mutant flies ([@B46]). Importantly, polyamines are candidate substances for treating not only AMI: ongoing clinical trials investigate the effect of spermidine-rich plant extracts on longevity ([@B68]; [@B127]).

Additional Autophagy Enhancers That Potentially Promote Longevity
-----------------------------------------------------------------

Metformin, a commonly used drug to treat type 2 diabetes, is a potent activator of AMPK and also a potential candidate lifespan extending and autophagy-inducing agent ([@B87]). Metformin has beneficial effects on the lifespan of mice ([@B90]). However, metformin failed to induce longevity in flies even though the treatment potently activated AMPK ([@B134]), suggesting that its effect may not be universal.

Non-steroid anti-inflammatory drugs are widely used in the clinics, and one of the most prevalent agents is aspirin. In line with this, aspirin was found to also promote longevity and healthspan in flies ([@B27]; [@B136]). As a relatively minor side effect, increased risk of gastrointestinal bleeding was reported earlier ([@B87]). However, a very recent study concluded that the use of low-dose aspirin was associated with an increased risk of intracranial hemorrhage, a major bleeding in the brain associated with a high risk of mortality ([@B52]). Thus, preventive low-dose aspirin treatment can no longer be considered as low-risk.

Conclusion
==========

Are we getting closer to finding the fountain of youth? While we understand several aspects of aging by now, we are far from having the whole picture. Various studies using Drosophila and other animal models show that several signaling pathways and interventions have well-established roles in the modulation of the aging process, as discussed in this review (summarized in [Figure 1](#F1){ref-type="fig"}). Drosophila can be the first-line model to test hundreds of potential longevity-enhancers in a multicellular organism. Its advantage is clear as it suits well the investigation of cellular and systemic effects in a whole animal, and promising candidate treatments can be easily adapted to mammalian models. The conserved features of the main longevity pathways presume that the selected agents will have similar effects in mammals as well. New strategies and combinations of various agents that fine-tune autophagic activity can be selected based on Drosophila experiments. Increasing the specificity and efficacy of these autophagy-enhancers may also help controlling side effects.

![Anti-aging pathways in different tissues of Drosophila. The main pathways and proteins that counteract with aging in fat tissue, brain, intestine and skeletal muscle of Drosophila. Green: mechanisms and proteins that have anti-aging effects when they are activated or their levels are elevated. Red: mechanisms and proteins that have anti-aging effects when they are inhibited or their levels are decreased. Blue and magenta arrows represent activation and inhibition, respectively. DR, dietary restriction; Tor, Target of Rapamycin pathway; Foxo, forkhead box O transcription factor pathway; DILP, Drosophila Insulin-Like Peptide; AMPK, AMP-activated kinase. Please see text for further details.](fcell-07-00140-g001){#F1}

One caveat of model animal studies is that human health and lifespan is strongly influenced by social and economic factors. Regardless of this major issue, we can certainly make general recommendations for a healthy lifestyle that includes regular exercise and permanent or intermittent caloric restriction (fasting), but these require serious efforts and engagement. It would be much easier to take some sort of food supplement, wouldn't it? The potential use of caloric restriction mimetics discussed here and also in a recent review ([@B87]) may provide a solution. For example, it would be feasible to regularly eat spermidine-rich food, perhaps in combination with other agents that enhance autophagy and induce longevity, as their mechanisms of action are complex and only partially overlap ([@B86]).
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